|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.98 NGN | 0.00% |
|
+10.00% | +2.06% |
Neimeth International Pharmaceuticals Plc reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was NGN 2,209.59 million compared to NGN 3,457.04 million a year ago. Net loss was NGN 2,580.66 million compared to net income of NGN 19.14 million a year ago.
Basic loss per share from continuing operations was NGN 0.6 compared to basic earnings per share from continuing operations of NGN 0.01 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +2.06% | 6.24M | |
| +26.47% | 664B | |
| +25.70% | 567B | |
| -6.33% | 354B | |
| +19.35% | 330B | |
| +4.23% | 286B | |
| +13.42% | 234B | |
| +4.71% | 199B | |
| -10.10% | 196B | |
| -4.04% | 148B |
NEIMETH INTERNATIONAL PHARMACEUTICALS PLC 
